BF
BOK Financial Portfolio holdings
AUM
$6.17B
1-Year Return
16.76%
This Quarter Return
+9.82%
1 Year Return
+16.76%
3 Year Return
+71.13%
5 Year Return
–
10 Year Return
–
AUM
$6.17B
AUM Growth
+$519M
(+9.2%)
Cap. Flow
+$88.2M
Cap. Flow
% of AUM
1.43%
Top 10 Holdings %
Top 10 Hldgs %
32.77%
Holding
1,369
New
89
Increased
306
Reduced
494
Closed
221
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$33.2M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$32.3M |
| 3 |
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$24.2M |
| 4 |
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$18.1M |
| 5 |
Simon Property Group
SPG
|
+$14.2M |
Top Sells
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$22.5M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$16.7M |
| 3 |
Coterra Energy
CTRA
|
+$15.6M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$6.33M |
| 5 |
Public Service Enterprise Group
PEG
|
+$5.98M |
Sector Composition
| 1 | Technology | 15.95% |
| 2 | Financials | 8.86% |
| 3 | Energy | 6.94% |
| 4 | Healthcare | 6.06% |
| 5 | Industrials | 5.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
PJT Partners
PJT
$4.47B
| $480K | 0.01% |
2,908
-397
| -12% | -$65.5K |
|
577
Pacira BioSciences
PCRX
$1.22B
| $477K | 0.01% |
19,976
-101
| -0.5% | -$2.41K |
|
578
Lantheus
LNTH
$3.6B
| $477K | 0.01% |
5,828
+1,566
| +37% | +$128K |
|
579
The Ensign Group
ENSG
$9.69B
| $476K | 0.01% |
3,087
-482
| -14% | -$74.4K |
|
580
Select Medical
SEM
$1.55B
| $476K | 0.01% |
31,370
+4,490
| +17% | +$68.2K |
|
581
FirstCash
FCFS
$6.49B
| $476K | 0.01% |
3,522
-622
| -15% | -$84.1K |
|
582
Supernus Pharmaceuticals
SUPN
$2.55B
| $476K | 0.01% |
15,095
+894
| +6% | +$28.2K |
|
583
Donnelley Financial Solutions
DFIN
$1.5B
| $473K | 0.01% |
7,665
-2,556
| -25% | -$158K |
|
584
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$15.7B
| $473K | 0.01% |
+9,400
| New | +$473K |
|
585
Winmark
WINA
$1.74B
| $469K | 0.01% |
1,241
-160
| -11% | -$60.4K |
|
586
Addus HomeCare
ADUS
$2.03B
| $468K | 0.01% |
4,059
-857
| -17% | -$98.7K |
|
587
Catalyst Pharmaceutical
CPRX
$2.44B
| $467K | 0.01% |
21,536
-1,049
| -5% | -$22.8K |
|
588
Harmony Biosciences
HRMY
$1.86B
| $467K | 0.01% |
14,779
+1,312
| +10% | +$41.5K |
|
589
Collegium Pharmaceutical
COLL
$1.18B
| $466K | 0.01% |
15,744
+111
| +0.7% | +$3.28K |
|
590
Innoviva
INVA
$1.22B
| $462K | 0.01% |
22,973
-3,690
| -14% | -$74.1K |
|
591
Prestige Consumer Healthcare
PBH
$3.11B
| $460K | 0.01% |
5,765
+343
| +6% | +$27.4K |
|
592
Monster Beverage
MNST
$63.2B
| $456K | 0.01% |
7,285
-811
| -10% | -$50.8K |
|
593
Frontdoor
FTDR
$4.83B
| $456K | 0.01% |
7,732
-3,692
| -32% | -$218K |
|
594
Archer Daniels Midland
ADM
$29.6B
| $456K | 0.01% |
8,632
-173
| -2% | -$9.13K |
|
595
Quanta Services
PWR
$57B
| $455K | 0.01% |
1,204
-15
| -1% | -$5.67K |
|
596
Vanguard High Dividend Yield ETF
VYM
$65B
| $454K | 0.01% |
3,404
+121
| +4% | +$16.1K |
|
597
M/I Homes
MHO
$4.07B
| $452K | 0.01% |
4,031
+505
| +14% | +$56.6K |
|
598
Perdoceo Education
PRDO
$2.26B
| $451K | 0.01% |
13,811
-3,278
| -19% | -$107K |
|
599
Buckle
BKE
$3.04B
| $449K | 0.01% |
9,911
-1,546
| -13% | -$70.1K |
|
600
G-III Apparel Group
GIII
$1.12B
| $449K | 0.01% |
+20,030
| New | +$449K |
|